These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Thyroid autoimmunity and general autoimmunity]. Orgiazzi J Rev Med Interne; 1999; 20 Suppl 1():12S-13S. PubMed ID: 10436906 [No Abstract] [Full Text] [Related]
25. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. Söderbergh A; Myhre AG; Ekwall O; Gebre-Medhin G; Hedstrand H; Landgren E; Miettinen A; Eskelin P; Halonen M; Tuomi T; Gustafsson J; Husebye ES; Perheentupa J; Gylling M; Manns MP; Rorsman F; Kämpe O; Nilsson T J Clin Endocrinol Metab; 2004 Feb; 89(2):557-62. PubMed ID: 14764761 [TBL] [Abstract][Full Text] [Related]
26. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I. Velloso LA; Winqvist O; Gustafsson J; Kämpe O; Karlsson FA Diabetologia; 1994 Jan; 37(1):61-9. PubMed ID: 8150232 [TBL] [Abstract][Full Text] [Related]
27. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome. Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Goswami R; Brown EM; Kochupillai N; Gupta N; Rani R; Kifor O; Chattopadhyay N Eur J Endocrinol; 2004 Jan; 150(1):9-18. PubMed ID: 14713274 [TBL] [Abstract][Full Text] [Related]
32. [APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms]. Gustafsson J; Alimohammadi M; Ekwall O; Gebre-Medhin G; Halldin-Stenlid M; Hedstrand H; Landgren E; Nilsson T; Rorsman F; Sköldberg F; Winqvist O; Kämpe O Lakartidningen; 2004 Jun; 101(24):2096-8, 2101-3. PubMed ID: 15282984 [TBL] [Abstract][Full Text] [Related]
33. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis. Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864 [TBL] [Abstract][Full Text] [Related]